BioMarin Pharmaceutical | Le Coût Des Ventes



Cost Of Sales Changement Date
Acadia Pharmaceuticals USD 21.8M 2.95M 2024-12
Agios Pharmaceuticals USD 1.08M 175K 2025-03
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
Amgen USD 2.6B 507M 2025-03
Bayer EUR 5.72B 633M 2024-12
Biogen USD 629.3M 45.8M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Insmed USD 26.15M 4.98M 2024-12
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
Moderna USD 90M 456M 2025-03
Neurocrine Biosciences USD 9.3M 1.3M 2024-12
PTC Therapeutics USD 12.86M 3.42M 2025-03
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.27B 1.81B 2024-12
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
Ultragenyx Pharmaceutical USD 28.66M 11.77M 2025-03
United Therapeutics USD 277.5M 201.6M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



BioMarin Pharmaceutical Le Coût Des Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.